News About: Pharm. Industry
Listed pharmas with women officer ratio less than 8%
It is even less than 1 of 10 officers in Korean listed pharmaceutical companies were reportedly women, which criticizes that the Korean pharmaceutical industry is an field with thick glass ceiling.
Yakup Shinmoon(www...
GC Pharm to develop next-gen premium vaccine in U.S.
GC Pharm will develop a next-generation premium vaccine in the U.S.
GC Pharm(CEO Eun-Cheol Huh) announced on the 21st that the company would found a new company called ‘CUREVO’ in Seattle, Washington and start to dev...
Allergan Korea appoints Ji-Hyun Kim as new branch manager
Allergan Korea recruited CEO Ji-Hyun Kim as a new branch manager on 15 May.
CEO Ji-Hyun Kim has been evaluated as a person qualified to continuously lead the growth of Allergan Korea as showing business insight and l...
DHP Korea acquire German EU GMP for disposable eyewashes
DHP Korea(CEO Dae-Hoon Yeo), a company specializing in disposable eyewash products, acquired the EU GMP certificate from the Federal Ministry of Health(Germany) on 18 May.
The certificate means the overall manufactur...
Kuhnil Pharm transfers Omacor technology back to original Italian pharma
Kuhnil Pharm(CEO Young-Joong Kim) signed a license-out and export agreement of ‘Rosumega SC’ with Italian Società Prodotti Antibiotici(hereinafter referring to S.p.A) on 10 May.
Under the agreement, Kuhnil Pharm will...
Daewoong Pharmaceutical acquires cGMP approval of Nabota factory from US FDA
Daewoong Pharmaceutical(CEO Seung-Ho Jeon) received an establishment inspection report(EIR) which mentioned approval for the Nabota(prabotulinumtoxin A, DWP-450) manufacturing facility from the US Food and Drug Admini...
1 of 3 listed pharmas with SG&A ration higher than 40%
1 of 3 listed pharmaceutical companies reportedly have a SG&A expense/sales ratio higher than 40%.
Yakup Shinmoon(www.yakup.com) analyzed 2018 1st quarter business performances that 62 listed pharmaceutical companies...
1st group of the pharma industry to complete ‘ISO 37001’ process by this June
The ‘ISO 37001’ certification program that the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) decided to take to raise the Korean pharmaceutical companies’ ethical management into the global leve...
Samil Pharmaceutical signs co-sales agreement of ‘Lastacaft Soln’ with Allergan
Samil Pharmaceutical(CEO Seung-Beom Huh) announced on 14 Mary that the company signed a distribution and co-sales agreement of Lastacaft Ophthalmic Solution 0.25% 5mL(alcaftadine), an allergic conjunctivitis therapy, ...
Celltrion Healthcare’s ‘Herzuma’ had first prescription in Germany
‘Herzuma(generic name: trastuzumab),’ an antibody biosimilar for the treatment of breast cancer and stomach cancer, Celltrion Healthcare is actively selling in the world had the first prescription in Germany as it did...
